Endotronix Announces Positive Data from SIRONA 2 in Late-Breaking Clinical Trial Session
Lisle, Illinois, USA. 23 May 2022. Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), today announced positive data from the SIRONA 2 clinical trial evaluating safety and efficacy of its Cordella™ Pulmonary Artery Pressure Sensor System (Cordella Sensor) in New York Heart Association (NYHA) class […]
Endotronix Announces Positive Data from SIRONA 2 in Late-Breaking Clinical Trial Session Read More »